Dr. Jamal Temsamani, Director of Drug Development, will give an invited talk at the Boulder Peptide Symposium.
This talk, entitled “Development of a vectorised neurotensin for therapeutic hypothermia” will be presented on September 29 in Session I-Peptides in the Clinic.
Boulder Peptide Symposium is the key forum for bringing together key decision leaders from both industry and academia to discuss the future of peptide therapeutics. This Symposium seeks to advance the development of effective peptide therapeutics that can be challenged by limited delivery routes, product stability, manufacturing challenges and an evolving regulatory landscape.